Clinical Trial

Trial Protocol ID USOR 21270_ZN-c3-005 *RIT* on HOLD effective 09/20/2024

Trial Description

A Phase 2 Open-Label, Multicenter Study to Evaluate Efficacy and Safety of ZN-c3 in Subjects with High-Grade Serous Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

View on ClinicalTrials.gov

Contact us regarding Clinical Trials at MOHRSCH@usoncology.com or call us at 877-664-7724

Investigator

  • Syed Shahid Mahmood, MD

Disease Types

Sponsor

  • Zentalis Pharmaceuticals

ClinicalTrials.gov NCT ID

  • NCT05128825